Treatment News : Pneumonia Vaccine Effective in HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 4, 2008

Pneumonia Vaccine Effective in HIV

People with HIV who are given the pneumococcal polysaccharide vaccine (PPV) are 35 percent less likely to develop pneumonia than those who are not vaccinated, according to a new study to be published in an upcoming issue of Clinical Infectious Diseases.

The Centers for Disease Control and Prevention (CDC) recommends that all people living with HIV receive PPV, with revaccination every five years. Many types of vaccines, however, do not work as well in people living with HIV, and there has been some doubt among researchers and health care providers regarding the effectiveness of the PPV in people who are HIV-positive.

To explore the effectiveness of the vaccine, Maria Rodriguez-Barradas, MD, of the Veterans Affairs (VA) Medical Center and Department of Medicine at Baylor College of Medicine in Houston, and her colleagues studied 1,626 male patients from the VA health system, 692 of whom were HIV negative and 934 who were HIV positive. Sixty-nine percent of the HIV-positive patients had been vaccinated compared with 46 percent of the HIV-negative patients.

Though the majority of the HIV-positive group were 50 years of age or older, they tended to be younger than the HIV-negative patients, and there were more HIV-positive African Americans and smokers.

Overall, six percent of the patients developed pneumonia during the study period. People with HIV were almost six times as likely to develop pneumonia as their HIV-negative counterparts. Having a low CD4 count and being a smoker also increased a person’s chance of developing pneumonia.

After controlling for HIV-specific factors like CD4 count, Dr. Rodriguez-Barradas’ team found that people with HIV who had been vaccinated were 35 percent less likely than those who had not been vaccinated to develop pneumonia. Conversely, vaccination did not reduce the risk of developing pneumonia in the HIV-negative patients. The authors state that the small number of HIV-negative people in the study, rather than the ineffectiveness of the vaccine, may have been responsible for this result.

The authors concluded that, among HIV-positive people, PPV vaccination offers significant protection against pneumonia. Smoking cessation, they stress, should be pursued as an additional strategy for preventing pneumonia.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (2 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.